CVS Health Corporation

CVS Healthcare Healthcare Plans

CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024. In the quarter to June 2026, revenue grew 7.26%, EPS grew 187.7%, free cash flow grew 338.3% and total debt fell 7.64%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten.

92.36 0.22 −0.24%
Market cap
$118.4B
P/E
24.1×
Fwd P/E
15.4×
Dividend yield
3.60%
F-score
7/9
Altman Z
2.26
Beneish M
−2.64
Dividend safety
43/100

CVS Health Corporation (CVS) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, CVS Health Corporation (CVS) trades at a EV/EBITDA of 8.9×. Over the past ten years it has ranged from 6.7× (December 2018) to 15.5× (December 2022); the current reading is higher than 44% of that period. That is below the Healthcare Plans industry median of 11.5× and in line with the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 10.3× 20.90%
FY2024 8.5× 0.22%
FY2023 8.5× (34.61%)
FY2022 13.0× 31.94%
FY2021 9.9× 26.36%
FY2020 7.8× (18.74%)
FY2019 9.6× (8.50%)
FY2018 10.5× 27.77%
FY2017 8.2× (4.22%)
FY2016 8.6× (26.10%)

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 9.7× 10.47%
Mar 2026 8.8× (14.83%)
Dec 2025 10.3× 4.58%
Sep 2025 9.9× (4.10%)
42 more quarters

Against its own ten years

Low 6.7× High 15.5×
Ten-year median 9.3×
Current reading's percentile 44

EV/EBITDA against peers

Company EV/EBITDA
CNC Centene Corporation compare n/m
CLOV Clover Health Investments, Corp. compare n/m
CI Cigna Group compare 8.3×
CVS CVS Health Corporation 8.9×
OSCR Oscar Health, Inc. compare 9.4×
ELV Elevance Health, Inc. compare 9.8×
HUM Humana Inc. compare 11.5×
MOH Molina Healthcare, Inc compare 15.3×
UNH UnitedHealth Group Incorporated compare 15.5×
Healthcare Plans industry median 11.5×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on CVS